Georgetown University Medical Center Innovation Center for Biomedical Informatics (ICBI) is a leading research institution focused on advancing in silico cancer research and data-mining methodologies. As part of the In Silico Research Centers of Excellence Program, Georgetown ISRCE collaborates with other centers to utilize informatics technologies and existing data to gain new insights into common cancer types, particularly breast, gastrointestinal, colorectal, and pancreatic cancers. Their goal is to improve survival rates and therapeutic outcomes through the development of innovative data analysis and mining workflows and algorithms.
Georgetown ISRCE specializes in analyzing various types of data, including gene expression, copy number, pathway networks, miRNA, and metabolomics data. They have also begun analyzing next-generation sequencing (NGS) data, such as RNA-seq, ChIP-seq, whole genome, and exome sequencing. Through their research efforts, Georgetown ISRCE aims to contribute to the advancement of cancer research and ultimately enhance the understanding, diagnosis, treatment, and prevention of cancer.
Generated from the website